Login
Home / 000513.SZ : SHZ
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Livzon Pharmaceutical Group Inc.

¥26.74 -$8.41 (-23.93%)
SHZ · 15 Sep 2026 03:25 UTC
Previous Close
¥27
Day Range
¥26.67¥27.28
Year Range
¥25.74¥40.65
Market Cap
23.74B
AVG Volume
6.38M
Trailing/Forward PE
14.15/11.46
PEG ratio
2.07
Dividend Yield
5.35%
Next Earnings Date
2026-10-27
Primary Exchange
Shenzhen Stock ExchangeCN
Revenue (CNY)
01B2B3B4B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (CNY)
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (CNY)
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (CNY)
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (CNY)
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (CNY)
00.20.40.60.824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (CNY)
0500M1B1.5B2BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (CNY)
05B10B15BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-4-3-2-1024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
0%2%4%6%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (CNY)
00.511.52Jul 17Jun 18Jul 19Jun 20Jun 21May 22Jul 23Jul 24Jun 25Jun 26
Book Value Per Share (CNY)
0510152024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (CNY)
010B20B30B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
1214161820med 15.39Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
4%6%8%10%12%med 8.31%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
22.533.5med 2.72Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
5678910med 7.94Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
68101214med 9.89Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
1.51.7522.252.5med 2.15Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Livzon Pharmaceutical Group Inc.
000513.SZ
Stockpicker

Video analysis: 000513.SZ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.